CN104334742A - 解析和定量无细胞rna的方法 - Google Patents

解析和定量无细胞rna的方法 Download PDF

Info

Publication number
CN104334742A
CN104334742A CN201380017554.6A CN201380017554A CN104334742A CN 104334742 A CN104334742 A CN 104334742A CN 201380017554 A CN201380017554 A CN 201380017554A CN 104334742 A CN104334742 A CN 104334742A
Authority
CN
China
Prior art keywords
rna
tissue
cell
sample
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380017554.6A
Other languages
English (en)
Chinese (zh)
Inventor
L·C·W·蔻
S·R·魁克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Priority to CN201810084289.8A priority Critical patent/CN108359711A/zh
Publication of CN104334742A publication Critical patent/CN104334742A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869—Methods for sequencing
    • C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F18/00—Pattern recognition
    • G06F18/20—Analysing
    • G06F18/21—Design or setup of recognition systems or techniques; Extraction of features in feature space; Blind source separation
    • G06F18/213—Feature extraction, e.g. by transforming the feature space; Summarisation; Mappings, e.g. subspace methods
    • G06F18/2135—Feature extraction, e.g. by transforming the feature space; Summarisation; Mappings, e.g. subspace methods based on approximation criteria, e.g. principal component analysis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Databases & Information Systems (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Bioethics (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Biomedical Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Chemical Kinetics & Catalysis (AREA)
CN201380017554.6A 2012-01-27 2013-01-28 解析和定量无细胞rna的方法 Pending CN104334742A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201810084289.8A CN108359711A (zh) 2012-01-27 2013-01-28 解析和定量无细胞rna的方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261591642P 2012-01-27 2012-01-27
US61/591,642 2012-01-27
PCT/US2013/023471 WO2013113012A2 (en) 2012-01-27 2013-01-28 Methods for profiling and quantitating cell-free rna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201810084289.8A Division CN108359711A (zh) 2012-01-27 2013-01-28 解析和定量无细胞rna的方法

Publications (1)

Publication Number Publication Date
CN104334742A true CN104334742A (zh) 2015-02-04

Family

ID=48874081

Family Applications (2)

Application Number Title Priority Date Filing Date
CN201380017554.6A Pending CN104334742A (zh) 2012-01-27 2013-01-28 解析和定量无细胞rna的方法
CN201810084289.8A Pending CN108359711A (zh) 2012-01-27 2013-01-28 解析和定量无细胞rna的方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201810084289.8A Pending CN108359711A (zh) 2012-01-27 2013-01-28 解析和定量无细胞rna的方法

Country Status (9)

Country Link
US (15) US20130252835A1 (https=)
EP (2) EP2807277A4 (https=)
JP (2) JP6320302B2 (https=)
CN (2) CN104334742A (https=)
AU (1) AU2013211850B8 (https=)
CA (1) CA2863035C (https=)
HK (1) HK1211624A1 (https=)
SG (2) SG11201505515XA (https=)
WO (1) WO2013113012A2 (https=)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108369612A (zh) * 2015-11-04 2018-08-03 梅塔博隆股份有限公司 自动化样品质量评估
WO2018210275A1 (en) * 2017-05-16 2018-11-22 The Chinese University Of Hong Kong Integrative single-cell and cell-free plasma rna analysis
US10155986B2 (en) 2012-01-27 2018-12-18 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
CN111566228A (zh) * 2017-10-23 2020-08-21 陈扎克伯格生物中心公司 用于在胎儿孕育中预测胎龄和早产的无创分子钟
CN112424372A (zh) * 2019-01-24 2021-02-26 Illumina公司 用于监测器官健康和疾病的方法和系统
US11773447B2 (en) 2014-11-14 2023-10-03 Nanthealth Labs, Inc. Use of circulating cell-free RNA for diagnosis and/or monitoring cancer
US11845988B2 (en) 2019-02-14 2023-12-19 Mirvie, Inc. Methods and systems for determining a pregnancy-related state of a subject
US12565679B2 (en) 2012-01-27 2026-03-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8583380B2 (en) 2008-09-05 2013-11-12 Aueon, Inc. Methods for stratifying and annotating cancer drug treatment options
HUE052213T2 (hu) 2009-11-06 2021-04-28 Univ Leland Stanford Junior Grafitkilökõdés nem invazív diagnosztizálása szervátültetett betegekben
RU2565550C2 (ru) 2010-09-24 2015-10-20 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Прямой захват, амплификация и секвенирование днк-мишени с использованием иммобилизированных праймеров
WO2015069900A1 (en) * 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
US10689652B2 (en) 2013-10-02 2020-06-23 The Regents Of The University Of California Methods for immortalization of epithelial cells
WO2015069933A1 (en) * 2013-11-06 2015-05-14 The Board Of Trustees Of The Leland Stanford Junior University Circulating cell-free dna for diagnosis of transplant rejection
JP7451070B2 (ja) * 2013-11-07 2024-03-18 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー ヒトミクロビオームおよびその成分の分析のための無細胞核酸
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
CN107922971A (zh) 2015-05-18 2018-04-17 凯锐思公司 用于富集核酸群体的组合物和方法
US10889861B2 (en) * 2015-06-17 2021-01-12 The Translational Genomics Research Institute Systems and methods for obtaining biological molecules from a sample
US10692797B2 (en) * 2015-06-30 2020-06-23 Laird Technologies, Inc. Thermal interface materials with low secant modulus of elasticity and high thermal conductivity
WO2017062517A1 (en) * 2015-10-06 2017-04-13 The Regents Of The University Of California Non-coding rnas linked to immortality and associated methods and compositions
CA3185611A1 (en) 2016-03-25 2017-09-28 Karius, Inc. Synthetic nucleic acid spike-ins
WO2018191563A1 (en) 2017-04-12 2018-10-18 Karius, Inc. Sample preparation methods, systems and compositions
WO2018208892A1 (en) * 2017-05-10 2018-11-15 Nantomics, Llc Circulating rna for detection, prediction, and monitoring of cancer
AU2018355575A1 (en) 2017-10-27 2020-05-21 Juno Diagnostics, Inc. Devices, systems and methods for ultra-low volume liquid biopsy
AU2018365883A1 (en) 2017-11-07 2020-05-14 Nanthealth Labs, Inc. Targeted cell free nucleic acid analysis
WO2019178157A1 (en) 2018-03-16 2019-09-19 Karius, Inc. Sample series to differentiate target nucleic acids from contaminant nucleic acids
US12462935B2 (en) 2018-03-30 2025-11-04 Nucleix Ltd. Deep learning-based methods, devices, and systems for prenatal testing
US12540319B2 (en) 2018-10-04 2026-02-03 Clearnote Health, Inc. Simultaneous, sequencing-based analysis of proteins, nucleosomes, and cell-free nucleic acids from a single biological sample
EP3874042A4 (en) * 2018-10-29 2023-06-28 Molecular Stethoscope, Inc. Characterization of bone marrow using cell-free messenger-rna
ES3059710T3 (en) 2018-11-21 2026-03-23 Karius Inc Direct-to-library methods, systems, and compositions
US11512349B2 (en) 2018-12-18 2022-11-29 Grail, Llc Methods for detecting disease using analysis of RNA
AU2020253585A1 (en) * 2019-04-02 2021-11-18 Mission Bio, Inc. Methods, systems, and apparatus for nucleic acid detection
CA3138806A1 (en) 2019-05-22 2020-11-26 Dalia Dhingra Method and apparatus for simultaneous targeted sequencing of dna, rna and protein
US11948684B2 (en) * 2019-06-20 2024-04-02 Latha Chakravarthy Diagnostic process for disease detection using gene expression based multi layer PCA classifier
CN110964800B (zh) * 2019-09-20 2021-10-22 北京航空航天大学 用于预测早产风险的cfRNA标志物
WO2021092224A1 (en) * 2019-11-05 2021-05-14 Cofactor Genomics, Inc. Methods and systems of processing complex data sets using artificial intelligence and deconvolution
AU2020378080B2 (en) * 2019-11-08 2026-02-19 Regeneron Pharmaceuticals, Inc. Accurate and robust information-deconvolution from bulk tissue transcriptomes
CA3162391A1 (en) * 2019-12-20 2021-06-24 Jesse Worth ROWLEY Methods and compositions for monitoring and diagnosing healthy and disease states
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
CN115701286A (zh) * 2020-03-18 2023-02-07 分子听诊器公司 使用无循环mRNA谱分析检测阿尔茨海默病风险的系统和方法
MX2023001781A (es) * 2020-08-13 2023-04-26 Mirvie Inc Metodos y sistemas para determinar un estado relacionado con el embarazo de un sujeto.
WO2024182491A1 (en) * 2023-02-28 2024-09-06 Virginia Commonwealth University Polygenic risk estimator for cervical length change during pregnancy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245376A (zh) * 2003-01-17 2008-08-20 香港中文大学 作为妊娠相关病症的诊断标志物的循环mRNA

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629147A (en) 1992-07-17 1997-05-13 Aprogenex, Inc. Enriching and identifying fetal cells in maternal blood for in situ hybridization
US5432054A (en) 1994-01-31 1995-07-11 Applied Imaging Method for separating rare cells from a population of cells
AU1853600A (en) * 1999-01-06 2000-07-24 Choong-Chin Liew Method for the detection of gene transcripts in blood and uses thereof
US20050123938A1 (en) * 1999-01-06 2005-06-09 Chondrogene Limited Method for the detection of osteoarthritis related gene transcripts in blood
US20080009467A1 (en) 2000-05-01 2008-01-10 Accera, Inc. Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
US6727066B2 (en) 2000-07-28 2004-04-27 Incyte Corporation Genes expressed in treated human C3A liver cell cultures
US6664056B2 (en) * 2000-10-17 2003-12-16 The Chinese University Of Hong Kong Non-invasive prenatal monitoring
US6977162B2 (en) * 2002-03-01 2005-12-20 Ravgen, Inc. Rapid analysis of variations in a genome
US20040067507A1 (en) 2002-05-10 2004-04-08 Nolan Timothy D. Liver inflammation predictive genes
WO2004007674A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Neuronal and retinal gene expression patterns
WO2004007673A2 (en) 2002-07-12 2004-01-22 The Johns Hopkins University Neuronal gene expression patterns
US20060003342A1 (en) * 2004-01-15 2006-01-05 Bianchi Diana W Fetal RNA in amniotic fluid to determine gene expression in the developing fetus
KR20070065869A (ko) * 2004-07-21 2007-06-25 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 타액 트랜스크립톰 진단법
US7713693B1 (en) * 2004-09-01 2010-05-11 University Of Louisiana At Monroe Human cancer cell specific gene transcript
US20060166242A1 (en) * 2005-01-06 2006-07-27 Mount Sinai Hospital Markers of pre-term labor
KR100686816B1 (ko) * 2005-07-22 2007-02-26 삼성에스디아이 주식회사 리튬 이차 전지
TR201910868T4 (tr) * 2006-02-02 2019-08-21 Univ Leland Stanford Junior Dijital analizle invazif olmayan fetal genetik tarama.
EP2302395B1 (en) 2006-06-07 2015-04-15 Health Diagnostic Laboratory, Inc. Markers associated with arteriovascular events and methods of use thereof
US20100145131A1 (en) * 2007-05-01 2010-06-10 Helena Grinberg-Rashi Methods and kits for predicting cancer metastasis
WO2009009457A1 (en) 2007-07-06 2009-01-15 University Of Louisville Research Foundation, Inc. Alzheimer's disease-specific micro-rna microarray and related methods
CN105400868B (zh) * 2007-08-22 2021-03-26 特罗瓦基因公司 使用miRNA检测体内细胞死亡情况的方法
WO2009073629A2 (en) * 2007-11-29 2009-06-11 Complete Genomics, Inc. Efficient shotgun sequencing methods
AU2009207291B2 (en) * 2008-01-27 2014-11-06 Mor Research Applications Methods and compositions for diagnosing complications of pregnancy
EP2283155A4 (en) * 2008-05-01 2011-05-11 Swedish Health Services DIAGNOSTIC TEST FOR BREAKFAST
WO2009143576A1 (en) 2008-05-27 2009-12-03 Adelaide Research & Innovation Pty Ltd Polymorphisms associated with pregnancy complications
US20110150775A1 (en) * 2008-06-01 2011-06-23 Tufts Medical Center, Inc. Genomic approaches to fetal treatment and diagnosis
US7888030B2 (en) * 2008-08-21 2011-02-15 King's College London Biomarkers
US20110263441A1 (en) 2008-10-15 2011-10-27 Golub Todd R Compositions, kits, and methods for identification, assessment, prevention, and therapy of hepatic disorders
PL2365804T3 (pl) 2008-11-13 2015-10-30 Modgene Llc Zmniejszanie obciążenia amyloidem-beta w tkance niemózgowej
EP2475781B1 (en) 2009-09-11 2017-10-25 The Chinese University Of Hong Kong Methods for assessing liver pathologies
EP2475777A4 (en) * 2009-09-11 2013-03-06 Nugen Technologies Inc COMPOSITIONS AND METHODS FOR COMPLETE TRANSCRIPTOMAL ANALYSIS
CA2807050C (en) * 2009-12-08 2019-06-18 Ozlem Equils Diagnostic biomarker to identify women at risk for preterm delivery
WO2011156734A2 (en) * 2010-06-11 2011-12-15 Hitachi Chemical Co., Ltd. Method of characterizing vascular diseases
JP5755326B2 (ja) 2010-06-11 2015-07-29 日立化成株式会社 腎機能の特徴を決定する方法
JP2013531799A (ja) * 2010-07-08 2013-08-08 プロノタ エヌ．ヴェ． 妊娠の高血圧障害についてのバイオマーカー
WO2012012693A2 (en) * 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods for detecting signatures of disease or conditions in bodily fluids
ES2627120T3 (es) 2011-07-08 2017-07-26 Helmholtz-Zentrum für Infektionsforschung GmbH Medicamento para el tratamiento del cáncer de hígado
CA2838562A1 (en) 2011-08-08 2013-02-14 Eugenia Wang Biomarker for alzheimer's disease and/or mild cognitively impairment, and use thereof
EP2758538B1 (en) 2011-09-22 2018-10-31 Lineage Biosciences, Inc. Methods for analyzing heterogeneous samples
MX373248B (es) 2011-09-30 2020-05-11 Somalogic Operating Co Inc Prediccion de riesgo de evento cardiovascular y usos del mismo.
US20140304845A1 (en) 2011-10-31 2014-10-09 Merck Sharp & Dohme Corp. Alzheimer's disease signature markers and methods of use
WO2013113012A2 (en) 2012-01-27 2013-08-01 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free rna
US20160289762A1 (en) * 2012-01-27 2016-10-06 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiliing and quantitating cell-free rna
EP2825665B1 (en) 2012-03-14 2017-09-06 Ruprecht-Karls-Universität Heidelberg Epigenetic signatures as marker for cardiomyopathies and myocardial insufficiencies
SG11201506891YA (en) * 2013-03-12 2015-09-29 Agency Science Tech & Res Pre-eclampsia biomarkers
ES2662108T3 (es) 2013-03-15 2018-04-05 Somalogic, Inc. Biomarcadores de la enfermedad de hígado graso no alcohólico (EHGNA) y de la esteatohepatitis no alcohólica (EHNA) y usos de los mismos
EP3303629A1 (en) 2015-06-05 2018-04-11 Regulus Therapeutics Inc. Non-alcoholic fatty liver disease biomarkers
EP3712279B1 (en) 2015-09-14 2024-03-20 Genfit Methods for diagnosing and evaluating non-alcoholic steatohepatitis
US20190071795A1 (en) 2016-03-09 2019-03-07 Molecular Stethoscope, Inc. Methods and systems for detecting tissue conditions

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101245376A (zh) * 2003-01-17 2008-08-20 香港中文大学 作为妊娠相关病症的诊断标志物的循环mRNA

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12365947B2 (en) 2012-01-27 2025-07-22 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
US10155986B2 (en) 2012-01-27 2018-12-18 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
US10240204B2 (en) 2012-01-27 2019-03-26 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
US10240200B2 (en) 2012-01-27 2019-03-26 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
US10287632B2 (en) 2012-01-27 2019-05-14 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
US12565679B2 (en) 2012-01-27 2026-03-03 The Board Of Trustees Of The Leland Stanford Junior University Methods for profiling and quantitating cell-free RNA
US11773447B2 (en) 2014-11-14 2023-10-03 Nanthealth Labs, Inc. Use of circulating cell-free RNA for diagnosis and/or monitoring cancer
US12050228B2 (en) 2015-11-04 2024-07-30 Metabolon, Inc. Automated sample quality assessment
CN108369612A (zh) * 2015-11-04 2018-08-03 梅塔博隆股份有限公司 自动化样品质量评估
CN110869518A (zh) * 2017-05-16 2020-03-06 香港中文大学 整合式单细胞和游离血浆rna分析
TWI782020B (zh) * 2017-05-16 2022-11-01 香港中文大學 整合單細胞及血漿游離rna分析
WO2018210275A1 (en) * 2017-05-16 2018-11-22 The Chinese University Of Hong Kong Integrative single-cell and cell-free plasma rna analysis
CN111566228A (zh) * 2017-10-23 2020-08-21 陈扎克伯格生物中心公司 用于在胎儿孕育中预测胎龄和早产的无创分子钟
CN112424372A (zh) * 2019-01-24 2021-02-26 Illumina公司 用于监测器官健康和疾病的方法和系统
US11851706B2 (en) 2019-02-14 2023-12-26 Mirvie, Inc. Methods and systems for determining a pregnancy-related state of a subject
US11845988B2 (en) 2019-02-14 2023-12-19 Mirvie, Inc. Methods and systems for determining a pregnancy-related state of a subject

Also Published As

Publication number Publication date
US12365947B2 (en) 2025-07-22
EP2807277A4 (en) 2016-02-17
US20130252835A1 (en) 2013-09-26
US20160017420A1 (en) 2016-01-21
WO2013113012A2 (en) 2013-08-01
JP2015511122A (ja) 2015-04-16
AU2013211850A1 (en) 2014-09-18
JP2017063799A (ja) 2017-04-06
US20220290236A1 (en) 2022-09-15
US20220213549A1 (en) 2022-07-07
HK1211624A1 (en) 2016-05-27
US20170145508A1 (en) 2017-05-25
US20210363584A1 (en) 2021-11-25
CA2863035A1 (en) 2013-08-01
WO2013113012A3 (en) 2014-11-06
CN108359711A (zh) 2018-08-03
CA2863035C (en) 2023-08-29
US20200370121A1 (en) 2020-11-26
JP6320302B2 (ja) 2018-05-09
US10287632B2 (en) 2019-05-14
US20220042098A1 (en) 2022-02-10
AU2013211850A8 (en) 2017-06-29
US20220010381A1 (en) 2022-01-13
EP2807277A2 (en) 2014-12-03
US20170145507A1 (en) 2017-05-25
US10240200B2 (en) 2019-03-26
US20170145509A1 (en) 2017-05-25
US20180357379A1 (en) 2018-12-13
AU2013211850B2 (en) 2017-03-02
US10240204B2 (en) 2019-03-26
EP3584327A1 (en) 2019-12-25
SG11201505515XA (en) 2015-09-29
US10155986B2 (en) 2018-12-18
AU2013211850B8 (en) 2017-06-29
SG10201906331TA (en) 2019-08-27
US20190226029A1 (en) 2019-07-25
US20200362416A1 (en) 2020-11-19
US20260055464A1 (en) 2026-02-26

Similar Documents

Publication Publication Date Title
US12365947B2 (en) Methods for profiling and quantitating cell-free RNA
US20230250477A1 (en) Methods and systems for determining a pregnancy-related state of a subject
Koh et al. Noninvasive in vivo monitoring of tissue-specific global gene expression in humans
US20250306012A1 (en) Circulating rna signatures specific to preeclampsia
US12359256B2 (en) Circulating RNA signatures specific to preeclampsia
WO2015069900A1 (en) Methods for profiliing and quantitating cell-free rna
Koha et al. Noninvasive in vivo monitoring of tissue-specific global gene expression in humans

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB03 Change of inventor or designer information

Inventor after: L * C * W * Kou

Inventor after: S * R * Quebec

Inventor after: H-M * C * Fan

Inventor after: Pan Wenying

Inventor before: L * C * W * Kou

Inventor before: S * R * Quebec

COR Change of bibliographic data

Free format text: CORRECT: INVENTOR; FROM: KOH LIAN CHYE WINSTON STEPHEN R. QUAKE TO: KOH LIAN CHYE WINSTON STEPHEN R. QUAKE FAN HEI-MUN CHRISTINA PAN WENYING

RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20150204